Data regarding the importance of histone acetylation to the regulation of cell behavior has led to increased interest in the role of HDAC inhibitors (HDACi) as potential pharmacological agents, mainly for cancer prevention and treatment [13,14,15]. This evidence concerns the gene HDAC9 and cancer.